Blog - Page 2 of 5576 - QualityStocks

TuesdayMar 10, 2026 9:16 am

QualityStocksNewsBreaks – Frontieras North America to Host Groundbreaking for West Virginia Commercial Facility

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, announced it will host a groundbreaking ceremony on April 2, 2026, for its first commercial facility in Mason County, West Virginia. The estimated $850 million industrial project is expected to create approximately 300 full-time jobs with wages averaging three times the area’s average income, along with about 2,000 construction jobs during the build phase. The ceremony, scheduled for 11:30 a.m. ET, will include remarks from company leadership and federal and state officials, followed by a ceremonial groundbreaking. The company’s FASForm(TM) technology is designed to convert coal…

TuesdayMar 10, 2026 9:10 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Mobilizes Teams to Murdock Mountain for 2026 Field Season

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) announced that its environmental consultants and exploration team have mobilized to the Murdock Mountain Property, marking the official start of the company’s 2026 field season. Following several weeks of weather delays, crews have begun environmental baseline work, access inspections and field preparations to support an upcoming drill program, with drilling expected to begin soon as ground conditions continue to stabilize. In addition to advancing the core project, the company will begin exploring three additional lease applications…

TuesdayMar 10, 2026 9:00 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Adopts Shareholder Rights Plan

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has adopted a Shareholder Rights Plan and entered into a Shareholder Rights Plan Agreement with TMX Trust Company as rights agent, effective immediately. The plan, which is consistent with similar measures adopted by Canadian public companies and was not implemented in response to any specific takeover proposal, is designed to provide the company’s board and shareholders adequate time to evaluate any unsolicited takeover bid, explore value-enhancing alternatives and ensure shareholders receive full and fair value. The plan will be subject to…

TuesdayMar 10, 2026 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) Sets March 30 Call to Review Q4 Results, Including a $100M Run Rate by December 2027

Beeline Holdings will host a stakeholder call on March 30 to discuss Q4 2025 financial results and operational updates. The company reported quarterly double-digit revenue growth in 2025 and ended the year with over $50 million in Balance Sheet equity and no corporate debt. Beeline is scaling an AI-driven mortgage platform designed to shorten closing times and lower origination costs, and is expanding core mortgage, title, and home equity offerings heading into 2026. The company is positioning its products for millennials, gig-economy workers, and real estate investors, and recently introduced a blockchain-enabled home equity product, building SaaS revenue channels. Beeline…

TuesdayMar 10, 2026 9:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease

Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U.K. Medicines and Healthcare Products Regulatory Agency for the treatment of Behçet’s Disease. The designation represents the first step toward potential inclusion in the U.K.’s Early Access to Medicines Scheme, which allows patients with life-threatening or seriously debilitating conditions to access promising therapies earlier. The PIM designation was granted based on Phase 2 clinical data indicating that dusquetide may provide a significant advantage over existing treatments while demonstrating a favorable potential benefit-risk profile for patients with this rare inflammatory disorder. To view the full…

MondayMar 09, 2026 12:00 pm

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients Specifically, Liora’s Linac for Image Guided Hadron Therapy (“LiGHT”) System and LIXTE’s LB-100 work together to fight cancer As a result, the companies are building a new cancer care ecosystem that hopes to boost the effectiveness of treatments, while also help them be more accessible for a wider range of patients Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically,…

MondayMar 09, 2026 11:15 am

Renewal Fuels Inc. (RNWF) Expands Leadership and Targets 2026 Milestone for Texatron(TM) Fusion Platform

Appointment of fusion researcher Fabrice David adds scientific oversight as commercialization plans advance. Travis Yakimishyn joins as Chief Electrical & Power Systems Officer to lead utility-scale integration. The company is transitioning to American Fusion Inc. following its merger with Kepler Fusion Technologies, with filing and audits nearing completion as the company prepares for SEC reporting status. Management reiterates goal of deploying a 100-megawatt operational unit by year-end 2026, with Kepler‘s plan to sell electricity on a per-kilowatt basis to utilities and industrial customers. Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and…

MondayMar 09, 2026 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development

“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO. The designation provides incentives that may include protocol assistance, reduced regulatory fees and up to 10 years of market exclusivity following approval. Dusquetide is classified as an innate defense regulator, a type of compound designed to modulate the body’s innate immune system rather than suppress it outright. For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a…

MondayMar 09, 2026 9:55 am

QualityStocksNewsBreaks – Octane Announces Neuro Tech Forum 2026 to Be Held March 26-27 in Newport Beach

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape. The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster…

MondayMar 09, 2026 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring

The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the heart’s electrical signals from three distinct directions. HeartBeam’s strategy is built around addressing a long-standing gap in cardiac care. Looking forward, HeartBeam is focused on advancing both its hardware and software platforms. HeartBeam (NASDAQ: BEAT) stands at a pivotal point in its development as a medical technology company focused on transforming how cardiac arrhythmias are detected, evaluated and monitored. Headquartered in Santa Clara, California, HeartBeam is building a platform designed starting with its FDA-cleared synthesized 12-lead ECG system to bring…

Site Search

Company Search

QualityStocksNewsBreaks – Frontieras North America to Host Groundbreaking for West Virginia Commercial Facility

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Mobilizes Teams to Murdock Mountain for 2026 Field Season

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Adopts Shareholder Rights Plan

Beeline Holdings Inc. (NASDAQ: BLNE) Sets March 30 Call to Review Q4 Results, Including a $100M Run Rate by December 2027

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

Renewal Fuels Inc. (RNWF) Expands Leadership and Targets 2026 Milestone for Texatron(TM) Fusion Platform

Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development

QualityStocksNewsBreaks – Octane Announces Neuro Tech Forum 2026 to Be Held March 26-27 in Newport Beach

HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring

Market Basics

Newsletter Publishers

Public Companies